Decoy Therapeutics, Inc. (DCOY)
1.21
-0.02
(-1.63%)
USD |
NASDAQ |
Oct 30, 10:23
Decoy Therapeutics Market Cap : 0.6438M for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 29, 2026 | 0.6544M |
| October 28, 2026 | 0.5852M |
| October 27, 2026 | 0.548M |
| October 26, 2026 | 0.4896M |
| October 23, 2026 | 0.516M |
| October 22, 2026 | 0.548M |
| October 21, 2026 | 0.5692M |
| October 20, 2026 | 0.6038M |
| October 19, 2026 | 0.6224M |
| October 16, 2026 | 0.6224M |
| October 15, 2026 | 0.6544M |
| October 14, 2026 | 0.6224M |
| October 13, 2026 | 0.6597M |
| October 12, 2026 | 0.7608M |
| October 09, 2026 | 0.782M |
| October 08, 2026 | 0.8086M |
| October 07, 2026 | 0.8565M |
| October 06, 2026 | 0.8246M |
| October 05, 2026 | 0.8884M |
| October 02, 2026 | 0.9416M |
| October 01, 2026 | 0.9869M |
| September 30, 2026 | 1.048M |
| September 29, 2026 | 1.133M |
| September 28, 2026 | 1.229M |
| September 25, 2026 | 1.644M |
| Date | Value |
|---|---|
| September 24, 2026 | 1.654M |
| September 23, 2026 | 2.048M |
| September 22, 2026 | 1.649M |
| September 21, 2026 | 1.362M |
| September 18, 2026 | 1.479M |
| September 17, 2026 | 1.506M |
| September 16, 2026 | 1.538M |
| September 15, 2026 | 1.442M |
| September 14, 2026 | 1.442M |
| September 11, 2026 | 1.420M |
| September 10, 2026 | 1.452M |
| September 09, 2026 | 1.468M |
| September 08, 2026 | 1.399M |
| September 04, 2026 | 1.431M |
| September 03, 2026 | 1.532M |
| September 02, 2026 | 1.585M |
| September 01, 2026 | 1.628M |
| August 31, 2026 | 1.623M |
| August 28, 2026 | 1.543M |
| August 27, 2026 | 1.58M |
| August 26, 2026 | 1.601M |
| August 25, 2026 | 1.585M |
| August 24, 2026 | 1.654M |
| August 21, 2026 | 1.702M |
| August 20, 2026 | 1.745M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.537B |
| Alnylam Pharmaceuticals, Inc. | 23.14B |
| Anika Therapeutics, Inc. | 291.62M |
| Savara, Inc. | 978.73M |
| Vericel Corp. | 2.158B |
Market Cap Related Metrics
| PS Ratio | 2.175 |
| Price to Book Value | 0.1489 |
| Price | 1.21 |
| Earnings Yield | -3.91K% |